LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

Kodu・Aktsiate loetelu・Clover Health Investments Corp

Clover Health Investments Corp

Suletud

3.53 -4.08

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

3.52

Max

3.67

Põhinäitajad
By Trading Economics
Sissetulek	21M -1.3M
Müük	125M 462M
Aktsiakasum	0.051
Kasumimarginaal	-0.276
Töötajad	570
EBITDA	20M -808K

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+30.28% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	4. aug 2025

Turustatistika
By TradingEconomics
Turukapital	77M 1.8B
Eelmine avamishind	7.61
Eelmine sulgemishind	3.53

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

3.4 / 3.77 Toetus ja vastupanu

Clover Health Investments Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

21. mai 2025, 23:25 UTC

Kuumad aktsiad

Stocks to Watch: Navitas Semiconductor, Urban Outfitters, Lumen Technologies, LiveRamp

21. mai 2025, 21:57 UTC

Omandamised, ülevõtmised, äriostud

AT&T to Buy Lumen's Mass Markets Fiber Business for $5.75 Billion -- Update

21. mai 2025, 21:29 UTC

Omandamised, ülevõtmised, äriostud

Millicom to Acquire Telefónica's Operations in Uruguay

21. mai 2025, 21:01 UTC

Suurimad hinnamuutused turgudel

Nvidia Selects Navitas Semiconductor to Work on Next-Generation 800V HVDC Architecture

21. mai 2025, 23:49 UTC

Market Talk

Gold Edges Higher on Possible Investor Shift Away From Government Bonds -- Market Talk

21. mai 2025, 23:37 UTC

Market Talk

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

21. mai 2025, 23:33 UTC

Omandamised, ülevõtmised, äriostud

Vigil Neuroscience: Iluzanebart Return to Licensor Amgen to Occur Prior to Closing of Sanofi Deal

21. mai 2025, 23:32 UTC

Omandamised, ülevõtmised, äriostud

Vigil Neuroscience Sees Sanofi Deal Strengthening Development Path for Oral Small Molecule TREM2 Agonist Program

21. mai 2025, 23:32 UTC

Omandamised, ülevõtmised, äriostud

Vigil Neuroscience: Shareholders to Get Up to $10 a Share in Sanofi Deal >SAN.FR VIGL

21. mai 2025, 23:32 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

James Hardie's Weak Update Spurs Questions Before AZEK Vote -- Market Talk

21. mai 2025, 23:31 UTC

Omandamised, ülevõtmised, äriostud

Samsung Biologics: Remaining Entity to Focus on Contract Development & Manufacturing Organization Business

21. mai 2025, 23:30 UTC

Omandamised, ülevõtmised, äriostud

Samsung Biologics: Spun-Off Entity Tentatively Named Samsung Episholdings

21. mai 2025, 23:30 UTC

Omandamised, ülevõtmised, äriostud

Samsung Biologics: Separated Business Entity to Focus on R&D Affiliate Samsungbioepis, New Investment

21. mai 2025, 23:29 UTC

Omandamised, ülevõtmised, äriostud

Samsung Biologics to Spin off R&D Segment Into Separate Holdings Company

21. mai 2025, 23:28 UTC

Tulu

Singtel to Finance Buybacks Via Excess Capital Generated From Asset Recycling >Z74.SG

21. mai 2025, 23:27 UTC

Tulu

Singtel Sets Up S$2.0B Share-Buyback Program >Z74.SG

21. mai 2025, 23:26 UTC

Tulu

Singtel: Net Rose Due to Exceptional Gain From Partial Divestment of Comcentre Headquarters >Z74.SG

21. mai 2025, 23:26 UTC

Tulu

Singtel FY25 Rev S$14.15B Vs. S$14.13B >Z74.SG

21. mai 2025, 23:26 UTC

Tulu

Singtel FY25 Net S$4.02B Vs. Net S$795.0M >Z74.SG

21. mai 2025, 23:23 UTC

Omandamised, ülevõtmised, äriostud

Sanofi: VGL101, Vigil's Second Molecule Program, Isn't Being Acquired

21. mai 2025, 23:22 UTC

Peamised uudised

Walmart to Cut 1,500 Corporate Jobs in Restructuring -- WSJ

21. mai 2025, 23:22 UTC

Omandamised, ülevõtmised, äriostud

Sanofi Sees No Effect From Vigil Deal on 2025 Outlook >SAN.FR

21. mai 2025, 23:20 UTC

Omandamised, ülevõtmised, äriostud

Sanofi: Vigil Deal Enhances Early-Stage Pipeline, Includes VG-3927, Which Will Be Evaluated in Alzheimer's Disease Study

21. mai 2025, 23:18 UTC

Omandamised, ülevõtmised, äriostud

Sanofi to Buy Vigil Neuroscience for $8 a Share at Closing >SAN.FR VIGL

21. mai 2025, 23:04 UTC

Peamised uudised

EV Owners Face Annual Fee Under Proposed Tax Bill -- Barrons.com

21. mai 2025, 21:46 UTC

Peamised uudised

NBCUniversal Bids for MLB Rights That Were Dropped by ESPN -- WSJ

21. mai 2025, 21:42 UTC

Peamised uudised

Omandamised, ülevõtmised, äriostud

AT&T to Buy Lumen's Mass Markets Fiber Business for $5.75B -- Update

21. mai 2025, 21:14 UTC

Omandamised, ülevõtmised, äriostud

Millicom to Acquire Telefónica's Ops in Uruguay

21. mai 2025, 21:07 UTC

Peamised uudised

NBCUniversal Bids for Major League Baseball Rights ESPN Dropped, Sources Say -- WSJ

21. mai 2025, 21:06 UTC

Omandamised, ülevõtmised, äriostud

Uber Stock Is Dropping. Blame Elon Musk and Tesla. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Clover Health Investments Corp Prognoos

Hinnasiht

By TipRanks

30.28% tõus

12 kuu keskmine prognoos

Keskmine 4.69 USD 30.28%

Kõrge 6 USD

Madal 3.75 USD

Põhineb 4 Wall Streeti analüütiku instrumendi Clover Health Investments Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

4 ratings

Osta

Hoia

Müü

Põhineb 4 analüütiku instrumendi Clover Health Investments Corp aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

3.4 / 3.77Toetus ja vastupanu

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bullish.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Clover Health Investments Corp

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.